Based on the above studies, it is plausible that an exosome-based nano-drug delivery system loaded with thalidomide and SALL4-B siRNA inhibited SALL4-B and VEGF family gene expression in gastric cancer cells. This evidence concerns the gene VEGFA and gastric cancer.